Levonorgestrel
- Product NDC
- 73358-911
- 11-digit product format
- 733580911
- Labeler code
- 73358
- Product ID
- 73358-911_962fb10f-2419-4aef-9966-ab5c27c46f3b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Levonorgestrel
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Curae Pharma360 Inc.
- Application
- ANDA202380
- Marketing category
- ANDA
- Marketing start
- 2022-10-17
- Marketing end
- 0000-00-00
- Substance
- LEVONORGESTREL
- Active strength
- 2 mg/1
- Pharmacologic classes
- Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73358-911-01 | 73358091101 | 1 BLISTER PACK in 1 CARTON (73358-911-01) > 1 TABLET in 1 BLISTER PACK | 1 blister pack | 2022-10-17 | 0000-00-00 | No | No | Current |